抗逆转录病毒治疗女性HIV-1生殖道排出的患病率、程度及相关因素
研究纳入1114名接受抗逆转录病毒治疗(ART)的非洲女性,分析生殖道HIV-1 RNA排出与血浆病毒载量及ART时间的关系。血浆病毒载量不可测的访视中5.8%存在生殖道排出,可测者中为23.6%;预测因素包括HIV疾病分期、抗逆转录病毒方案及生殖器溃疡或宫颈触痛。
要点
- 血浆病毒载量不可测时仍有5.8%访视存在生殖道HIV-1排出。
- 血浆病毒载量可测时生殖道排出比例达23.6%,且排出程度随时间增加。
- HIV疾病分期、ART方案及生殖器溃疡或宫颈触痛可预测生殖道排出。
核心结论
- 接受ART的女性中,血浆病毒载量不可测时生殖道HIV-1排出仍持续存在,且排出程度不随时间改变。
研究设计与样本
- 纳入1114名接受ART的非洲女性的研究,采用线性及广义线性混合模型比较生殖道排出的程度与患病率,并用多变量logistic回归评估血浆病毒载量不可测者的预测因素。
主要发现
- 血浆病毒载量不可测的访视中5.8%有生殖道排出,可测的访视中23.6%有生殖道排出。
- 生殖道排出的预测因素为HIV疾病分期、抗逆转录病毒方案、生殖器溃疡或宫颈触痛。
临床怎么用
- 除ART外,应通过预防和治疗HIV相关疾病及生殖道感染来减少免疫激活,可能降低HIV-1生殖道排出及传播风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Genital human immunodeficiency virus (HIV) RNA shedding can continue despite HIV being undetectable in blood, and can be associated with transmission. METHODS: We included African women on antiretroviral therapy (ART). Linear and generalized linear mixed models were used to compare the magnitude and prevalence of genital shedding, respectively, by time since ART initiation. Multivariable logistic regression with generalized estimating equations was used to assess predictors of genital shedding among women with undetectable plasma viral load (VL). RESULTS: Among 1114 women, 5.8% of visits with undetectable plasma VL and 23.6% of visits with detectable VL had genital shedding. The proportion of visits with genital shedding decreased with time since ART initiation but the magnitude of shedding remained unchanged when plasma VL was undetectable (P = .032). Prevalence of shedding did not vary by time since ART initiation when plasma VL was detectable (P = .195), though the magnitude of shedding significantly increased (P = .04). Predictors of genital shedding were HIV disease stage, antiretroviral regimen, and genital ulcers or cervical tenderness. DISCUSSION: In addition to ART, reducing immune activation through prevention and treatment of HIV-related conditions and genital tract infections may decrease the risk of HIV-1 shedding and potential transmission.
引用
- King CC, Ellington SR, Davis NL, et al. Prevalence, Magnitude, and Correlates of HIV-1 Genital Shedding in Women on Antiretroviral Therapy. J Infect Dis. 2017. PMID: 29240922. doi:10.1093/infdis/jix550
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。